Bladder cancer is the 6th most common cancer in the US, yet significant disparities in access to guideline-concordant care persist—particularly among Black patients, women, older adults, uninsured individuals, and those in rural communities. For many patients with bladder cancer, access to personalized, high-quality care remains limited due to systemic inequities that impact timely diagnosis, treatment access, and use of supportive services. Overcoming these disparities requires data-driven strategies and a reimagining of care delivery grounded in equity.
ACCC provides resources to support cancer care professionals in identifying and addressing barriers to guideline-concordant care, helping ensure all patients receive equitable, evidence-based treatment.
Navigate the growing complexity of bladder cancer care using a framework for best practices developed by ACCC and the Bladder Cancer Advocacy Network (BCAN). Qualifying cancer programs/practices may join a public registry on BCAN.org.
Download Now
Each May, Bladder Cancer Awareness Month helps highlight the facts about bladder cancer, promote awareness about the disease, and call for more investment in research, treatment, and care. This year’s theme emphasizes the importance promoting conversations about bladder cancer and its symptoms, treatments, and management.
This is a visual representation of an online publication from the American Society of Clinical Oncology 2022 Annual Meeting, June 3 - 7, 2022.
